Clarifying the grey space of sugammadex induced bradycardia : Current Opinion in
Anesthesiology Clarifying the grey space of sugammadex induced bradycardia : Current …

Interventions: The patient received immediate treatment with atropine (0.5 mg) for
bradycardia. Glycopyrrolate (0.1 mg) and neostigmine (1 mg) were administered to improve …

Sugammadex has been used for more than ten years in Australia and New Zealand and has
been implicated as an effective treatment, and in some cases a potential cause, of a critical …

Kounis syndrome commonly is described as a complex multisystem phenomenon mainly
affecting coronary arteries, resulting in coronary vasospasm in the context of an allergic …

Aim Residual neuromuscular blockade is a common complication after general anaesthesia.
Sugammadex can reverse the action of aminosteroid neuromuscular blockers. This study …

Background Sugammadex is a novel agent that reverses neuromuscular blockade during
general anesthesia. Recent case reports have raised concerns regarding potential cardiac …

Administering sugammadex to reverse neuromuscular blockade can cause marked
bradycardia and rarely asystole. In this case, a rapid onset, biphasic heart rate response; …

Perioperative anaphylaxis is a rare, but life-threatening hypersensitivity reaction for patients
undergoing surgical procedures. Sugammadex is a relatively new drug used to reverse the …

Sugammadex-induced bradycardia is well known and the incidence is quoted to be around
0.6–1%. 1, 2 While the mechanism is unknown, sugammadex-induced bradycardia can be …

Neuromuscular block is commonly used in general anesthesia through the administration of
neuromuscular blocking agents (NMBAs) for both intubation of the trachea and to achieve …